APOLIPOPROTEIN A-II - ANVISA Registration 10345161142
Access comprehensive regulatory information for APOLIPOPROTEIN A-II in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345161142 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including ROCHE DIAGNOSTICS GMBH, BEIJING STRONG BIOTECHNOLOGIES, INC., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10345161142
25351143703200918
01449930000190
Company Information
Dates and Status
Aug 10, 2009
VIGENTE
09/18/2025 19:00:01
APOLIPOPROTEIN A-II
LPA2
ROCHE DIAGNOSTICS GMBH
10287411032
Dec 30, 2013
APOLIPOPROTEIN A-II
APOLIPOPROTEIN A II Assay Kit (APO A II)
BEIJING STRONG BIOTECHNOLOGIES, INC.
80464810871
Jan 02, 2024
LIPOPROTEIN
N APO E
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
10345161076
May 04, 2009
APOLIPOPROTEIN A-I
APOLIPROTEIN A1
BECKMAN COULTER INC.
10033120686
May 14, 2012
APOLIPOPROTEIN A-I
Apo A-I
LABORLAB PRODUTOS PARA LABORATÓRIOS LTDA EPP
10246810230
Dec 14, 2015